
Alan S. Chen
Examiner (ID: 1750, Phone: (571)272-4143 , Office: P/2124 )
| Most Active Art Unit | 2125 |
| Art Unit(s) | 2124, 2129, 2182, 2125 |
| Total Applications | 1749 |
| Issued Applications | 1501 |
| Pending Applications | 96 |
| Abandoned Applications | 174 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18737798
[patent_doc_number] => 20230346693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => HOT MELT EXTRUSION FOR PHARMACEUTICAL VAGINAL FILM PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/142667
[patent_app_country] => US
[patent_app_date] => 2023-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18142667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/142667 | HOT MELT EXTRUSION FOR PHARMACEUTICAL VAGINAL FILM PRODUCTS | May 2, 2023 | Abandoned |
Array
(
[id] => 19353057
[patent_doc_number] => 12053482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Oral formulations of cytidine analogs and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/138473
[patent_app_country] => US
[patent_app_date] => 2023-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 33508
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18138473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/138473 | Oral formulations of cytidine analogs and methods of use thereof | Apr 23, 2023 | Issued |
Array
(
[id] => 18784718
[patent_doc_number] => 20230372328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => ORAL DELAYED BURST FORMULATION OF LOW-DOSE NALTREXONE AND METHODS FOR TREATING FIBROMYALGIA AND LONG COVID
[patent_app_type] => utility
[patent_app_number] => 18/296247
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296247
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296247 | ORAL DELAYED BURST FORMULATION OF LOW-DOSE NALTREXONE AND METHODS FOR TREATING FIBROMYALGIA AND LONG COVID | Apr 4, 2023 | Pending |
Array
(
[id] => 18724184
[patent_doc_number] => 20230338306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/128328
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128328
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128328 | STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF | Mar 29, 2023 | Pending |
Array
(
[id] => 20066919
[patent_doc_number] => 20250205141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-26
[patent_title] => COMPOSITION SUITABLE FOR EYEBROWS
[patent_app_type] => utility
[patent_app_number] => 18/851634
[patent_app_country] => US
[patent_app_date] => 2023-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18851634
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/851634 | COMPOSITION SUITABLE FOR EYEBROWS | Mar 2, 2023 | Pending |
Array
(
[id] => 18536015
[patent_doc_number] => 20230241102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => FORMULATIONS OF CALCIUM AND PHOSPHATE FOR ORAL INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/113939
[patent_app_country] => US
[patent_app_date] => 2023-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18113939
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/113939 | FORMULATIONS OF CALCIUM AND PHOSPHATE FOR ORAL INFLAMMATION | Feb 23, 2023 | Abandoned |
Array
(
[id] => 19120093
[patent_doc_number] => 11964054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Formulations of tegavivint
[patent_app_type] => utility
[patent_app_number] => 18/106193
[patent_app_country] => US
[patent_app_date] => 2023-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 35
[patent_no_of_words] => 12172
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18106193
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/106193 | Formulations of tegavivint | Feb 5, 2023 | Issued |
Array
(
[id] => 18389732
[patent_doc_number] => 20230157950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => OROMUCOSAL FILM COMPOSITIONS COMPRISING EPINEPHRINE PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/159320
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159320
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159320 | OROMUCOSAL FILM COMPOSITIONS COMPRISING EPINEPHRINE PARTICLES | Jan 24, 2023 | Abandoned |
Array
(
[id] => 18373574
[patent_doc_number] => 20230148650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => NOVEL COATING COMPOSITION AND COATED COMPOSITIONS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/099831
[patent_app_country] => US
[patent_app_date] => 2023-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18099831
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/099831 | NOVEL COATING COMPOSITION AND COATED COMPOSITIONS COMPRISING THE SAME | Jan 19, 2023 | Abandoned |
Array
(
[id] => 19768266
[patent_doc_number] => 20250049692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => ANTIPERSPIRANT COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/719429
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18719429
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/719429 | ANTIPERSPIRANT COMPOSITION | Dec 7, 2022 | Pending |
Array
(
[id] => 19593215
[patent_doc_number] => 12151033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Foam compositions, foam matrices and methods
[patent_app_type] => utility
[patent_app_number] => 18/075283
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12135
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18075283
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/075283 | Foam compositions, foam matrices and methods | Dec 4, 2022 | Issued |
Array
(
[id] => 18603364
[patent_doc_number] => 11744804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Microcapsule powder stable in gastric acid, method for preparing same, and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/059470
[patent_app_country] => US
[patent_app_date] => 2022-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6260
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18059470
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/059470 | Microcapsule powder stable in gastric acid, method for preparing same, and use thereof | Nov 28, 2022 | Issued |
Array
(
[id] => 18267710
[patent_doc_number] => 20230088952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => PROCESS FOR PREPARING FILLED HARD-SHELL CAPSULES WITH (METH)ACRYLATE COPOLYMER BASED COATINGS WITH A CAPSULE-FILLING MACHINE
[patent_app_type] => utility
[patent_app_number] => 18/054741
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054741
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054741 | PROCESS FOR PREPARING FILLED HARD-SHELL CAPSULES WITH (METH)ACRYLATE COPOLYMER BASED COATINGS WITH A CAPSULE-FILLING MACHINE | Nov 10, 2022 | Pending |
Array
(
[id] => 18535999
[patent_doc_number] => 20230241086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/984939
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/984939 | ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF | Nov 9, 2022 | Abandoned |
Array
(
[id] => 19707692
[patent_doc_number] => 20250017834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => SUNSCREEN COMPOSITIONS COMPRISING IMINE ANALOGS OF A SUNSCREEN COMPRISING A KETONE
[patent_app_type] => utility
[patent_app_number] => 18/709341
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18709341
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/709341 | SUNSCREEN COMPOSITIONS COMPRISING IMINE ANALOGS OF A SUNSCREEN COMPRISING A KETONE | Nov 8, 2022 | Pending |
Array
(
[id] => 18241544
[patent_doc_number] => 20230073855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => SOFT GEL CAPSULE COMPRISING A SELECTIVE ESTROGEN RECEPTOR MODULATOR
[patent_app_type] => utility
[patent_app_number] => 18/053010
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053010 | SOFT GEL CAPSULE COMPRISING A SELECTIVE ESTROGEN RECEPTOR MODULATOR | Nov 6, 2022 | Abandoned |
Array
(
[id] => 18947110
[patent_doc_number] => 11890383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Capsules with opacifier
[patent_app_type] => utility
[patent_app_number] => 17/978780
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9317
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17978780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/978780 | Capsules with opacifier | Oct 31, 2022 | Issued |
Array
(
[id] => 18228377
[patent_doc_number] => 20230067371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => PHARMACOKINETICS OF COMBINED RELEASE FORMULATIONS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/974316
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17974316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/974316 | Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative | Oct 25, 2022 | Issued |
Array
(
[id] => 18326795
[patent_doc_number] => 20230124923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => INSTANT RELEASE PHARMACEUTICAL PREPARATION OF ANTICOAGULANT AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/969972
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969972 | Instant release pharmaceutical preparation of anticoagulant and preparation method therefor | Oct 19, 2022 | Issued |
Array
(
[id] => 18777902
[patent_doc_number] => 11819578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Nanofiber scaffolds
[patent_app_type] => utility
[patent_app_number] => 17/962149
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 21086
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962149 | Nanofiber scaffolds | Oct 6, 2022 | Issued |